Clinical Trial: "Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156864) titled '"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".' on Aug. 26.

Brief Summary: A two-stage open-label, prospective, safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity study with participation of healthy volunteers in three dose-escalation groups and patients with a confirmed diagnosis of COVID-19.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: COVID-19

Intervention: DRUG: 1/10 therapeutic dose

5 volunteers + 1 replacement volunteer will recieve 1/10 therapeutic dose of the s...